XML 33 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ 12,946 $ 392,750
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 32,586 28,004
Loss (gain) on derivative instruments 2,047 (40,343)
Cash settlements (paid) received on expired derivative instruments 17,616 (8,273)
Cash settlements received (paid) on terminated derivative instruments 793 658
Deferred income tax expense (benefit) 2,196 (253,796)
Accretion of asset retirement obligations 8,438 7,951
Share-based compensation (see Note 12) 6,799 5,280
Settlement of asset retirement obligations (1,170) (1,236)
Amortization and write-off of deferred financing costs 1,233 1,980
Bad debt expense 80 98
Changes in operating assets and liabilities:    
Accounts receivable (697) 41,262
Prepaid expenses and other assets (7,561) (482)
Payables and accrued liabilities (24,013) (31,501)
Other   (762)
Net cash provided by operating activities 51,293 141,590
Cash flows from investing activities:    
Additions to oil and gas properties (72,226) (30,667)
Additions to other property and equipment (1,118) (711)
Additions to restricted investments (10,057) (8,609)
Other 1,367 1,385
Net cash used in investing activities (82,034) (38,602)
Cash flows from financing activities:    
Advances on Revolving Credit Facility 117,000 125,000
Payments on Revolving Credit Facility (105,000) (200,000)
Deferred financing costs (136) (4,813)
Shares withheld for taxes (1,869) (2,429)
Net cash used in financing activities 9,995 (82,242)
Net change in cash and cash equivalents (20,746) 20,746
Cash and cash equivalents, beginning of period $ 20,746  
Cash and cash equivalents, end of period   $ 20,746